InvestorsHub Logo
Followers 65
Posts 23979
Boards Moderated 0
Alias Born 11/23/2016

Re: Bourbon_on_my_cornflakes post# 92909

Thursday, 02/23/2017 5:11:20 PM

Thursday, February 23, 2017 5:11:20 PM

Post# of 463927
The A2-73 composition of matter is protected in this case for cancer. Since Anavex have disclosed other indications, such as Alzheimer's based on the exact same molecule, I would think that preclude others from patenting this particular molecule in any disclosed indication.

It may be possible to improve on A2-73 in novel and non-obvious ways, but it seems to me that the A2-73 patent in the cancer indication offers decent protection for Anavex.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News